Endovenous laser ablation (EVLA) treats major varicose veins previously treated by stripping surgery. With ultrasound guidance, a laser fibre is placed into the abnormal vein through a tiny incision. The vein is then numbed with local anaesthetic, and the laser activated as the fibre is slowly removed. This produces a reaction in the vein wall along the treated section, resulting in collapse and sclerosis of the vein wall with minimal discomfort. Endovenous means inside the vein, so the next thing the doctor has to do is to get inside your vein. A small amount of local anaesthetic is injected into the skin over the vein and a needle inserted into it. A wire is passed through the needle and up the vein. The needle is removed and a catheter (thin plastic tubing) is passed over the wire, up the vein and the wire removed. A laser fibre is passed up the catheter so its tip lies at the highest point to be heated (usually your groin crease). A large quantity of local anaesthetic solution is then injected around the vein through multiple tiny needle pricks.
Market Dynamics
The key market players are focusing on adoption of growth strategies such as product launches, which is attributed to the growth of Global Endovenous Laser Therapy market. For instance, in October 2022, Medtronic plc, a healthcare technology and medical device company in U.S., announced the launch of Medtronic Neurovascular Co-Lab Platform designed to accelerate urgently needed innovation in stroke care and treatment.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook